Tetrahydrobiopterin and Nitric Oxide: Mechanistic and Pharmacological Aspects

Experimental Biology and Medicine

Volumn 228, Issue 11, 2003, Pages 1291-1302

  Werner, Ernst R ^a,d   Gorren, Antonius C F ^b   Heller, Regine ^c   Werner Felmayer, Gabriele ^a   Mayer, Bernd ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d Institute for Ion Physics and Applied Physics   (Austria)

Author keywords

Endothelial dysfunction; Nitric oxide synthase; Reaction mechanism; Tetrahydrobiopterin

Indexed keywords

CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN;

ALLOSTERISM; CELL FUNCTION; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENDOTHELIUM CELL; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; REACTION ANALYSIS; REVIEW; SHORT SURVEY; TREATMENT PLANNING;

EID: 0346848801     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322801108     Document Type: Short Survey

References (152)

1. Tayeh MA, Marletta M. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. J Biol Chem 264:19654-19658, 1989.
2. Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 264:20496-20501, 1989.
3. Werner ER, Werner-Felmayer G, Wachter H. Tetrahydrobiopterin and cytokines. Proc Soc Exp Biol Med 203:1-12, 1993.
4. Werner ER, Werner-Felmayer G, Mayer B. Tetrahydrobiopterin, cytokines, and nitric oxide synthesis. Proc Soc Exp Biol Med 219:171-182, 1998.
5. Werner-Felmayer G, Golderer G, Werner ER. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr Drug Metab 3:159-173, 2002.
6. Werner ER, Werner-Felmayer G. Biopterin analogues:novel nitric oxide synthase inhibitors with immunosuppressive action. Curr Drug Metab 3:119-121, 2002.
7. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, Roscher AA. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347:2122-2132, 2002.
8. Bernegger C, Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. Mol Genet Metab 77:304-313, 2002.
9. Blau N, Trefz FK. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: possible regulation of gene expression in a patient with the homozygous L48S mutation. Mol Genet Metab 75:186-187, 2002.
10. Pfeiffer S, Mayer B, Hemmens B. Nitric oxide - Chemical puzzles posed by a biological messenger. Angew Chem Int Ed 38:1714-1731, 1999.
11. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411:217-230, 1999.
12. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615, 2001.
13. Gorren ACF, Mayer B. Tetrahydrobiopterin in nitric oxide synthesis: A novel biological role for pteridines. Curr Drug Metab 3:133-157, 2002.
14. Siddhanta U, Presta A, Fan B, Wolan D, Rousseau DL, Stuehr DJ. Domain swapping in inducible nitric-oxide synthase. J Biol Chem 273:18950-18958, 1998.
15. Colasanti M, Venturini G. Nitric oxide in invertebrates. Mol Neurobiol 17:157-174, 1998.
16. Golderer G, Werner ER, Leitner S, Gröbner P, Werner-Felmayer G. Nitric oxide synthase is induced in sporulation of Physarum polycephalum. Genes Dev 15:1299-1309, 2001.
17. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ, Tainer JA. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279:2121-2126, 1998.
18. Raman CS, Li H, Martásek P, Král V, Masters BSS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95:939-950, 1998.
19. Vásquez-Vivar J, Hogg N, Martásek P, Karoui H, Pritchard KA Jr, Kalyanaraman B. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274:26736-26742, 1999.
20. Wei CC, Wang ZQ, Wang Q, Meade AL, Hemann C, Hille R, Stuehr DJ. Rapid kinetic studies link tetrahydrobiopterin radical formation to heme-dioxy reduction and arginine hydroxylation in inducible nitric oxide synthase. J Biol Chem 276:315-319, 2001.
21. List BM, Klosch B, Volker C, Gorren AC, Sessa WC, Werner ER, Kukovetz WR, Schmidt K, Mayer B. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity:tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J 323:159-165, 1997.
22. Presta A, Siddhanta U, Wu C, Sennequier N, Huang L, Abu-Soud HM, Erzurum S, Stuehr DJ. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry 37: 298-310, 1998.
23. Stroes E, Hijmering M, van Zandvoort M, Wever R, Rabelink TJ, van Faassen EE. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 438:161-164, 1998.
24. Vásquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BSS, Karoui H, Tordo P, Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase:the influence of cofactors. Proc Natl Acad Sci USA 95:9220-9225, 1998.
25. Xia Y, Roman LJ, Masters BSS, Zweier JL. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 273:22635-22639, 1998.
26. Pou S, Keaton L, Surichamorn W, Rosen GM. Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem 274:9573-9580, 1999.
27. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 276:14533-14536, 2001.
28. Yoneyama H, Yamamoto A, Kosaka H. Neuronal nitric oxide synthase generates superoxide from the oxygenase domain. Biochem J 360:247-253, 2001.
29. Xia Y, Tsai A-L, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. J Biol Chem 273:25804-25808, 1998.
30. Adak S, Wang Q, Stuehr DJ. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. J Biol Chem 275:33554-33561, 2000.
31. Adhikari S, Ray S, Gachhui R. Catalase activity of oxygenase domain of rat neuronal nitric oxide synthase. Evidence for product formation from L-arginine. FEBS Lett 475:35-38, 2000.
32. Rusche KM, Spiering MM, Marletta MA. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 37: 15503-15512, 1998.
33. ω-hydroxyarginine analogues and various N-hydroxyguanidines by NO synthase II:key role of tetrahydrobiopterin in the reaction mechanism and substrate selectivity. Chem Res Toxicol 14:202-210, 2001.
34. Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 68:355-381, 1999.
35. Bassan A, Blomberg MR, Siegbahn PE. Mechanism of dioxygen cleavage in tetrahydrobiopterin-dependent amino acid hydroxylases. Chemistry 9:106-115, 2003.
36. Gorren ACF, List BM, Schrammel A, Pitters E, Hemmens B, Werner ER, Schmidt K, Mayer B. Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. Biochemistry 35:16735-16745, 1996.
37. Rusche KM, Marletta MA. Reconstitution of pterin-free induciible nitric-oxide synthase. J Biol Chem 276:421-427, 2001.
38. Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem 13:13861-13866, 1994.
39. Gorren ACF, Schrammel A, Schmidt K, Mayer B. Effects of pH on the structure and function of neuronal nitric oxide synthase. Biochem J 331:801-807, 1998.
40. Kotsonis P, Fröhlich LG, Shutenko ZV, Horejsi R, Pfleiderer W, Schmidt HHHW. Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide. Biochem J 346:767-776, 2000.
41. Panda K, Rosenfeld RJ, Ghosh S, Meade AL, Getzoff ED, Stuehr DJ. Distinct dimer interaction and regulation in nitric-oxide synthase types I, II, and III. J Biol Chem 277:31020-31030, 2002.
42. Ghosh DK, Wu C, Pitters E, Moloney M, Werner ER, Mayer B, Stuehr DJ. Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. Biochemistry 36:10609-10619, 1997.
43. Abu-Soud HM, Wu C, Ghosh DK, Stuehr DJ. Stopped-flow analysis of CO and NO binding to inducible nitric oxide synthase. Biochemistry 37:3777-3786, 1998.
44. Huang L, Abu-Soud HM, Hille R, Stuehr DJ. Nitric oxide-generated P420 nitric oxide synthase: Characterization and roles for tetrahydrobiopterin and substrate in protecting against or reversing the P420 conversion. Biochemistry 38:1912-1920, 1999.
45. Reif A, Fröhlich LG, Kotsonis P, Frey A, Bömmel HM, Wink DA, Pfleiderer W, Schmidt HHHW. Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem 274:24921-24929, 1999.
46. Presta A, Weber-Main AM, Stankovich MT, Stuehr DJ. Comparative effects of substrates and pterin cofactor on the heme midpoint potential in inducible and neuronal nitric oxide synthases. J Am Chem Soc 120:9460-9465, 1998.
47. Slama-Schwok A, Negrerie M, Berka V, Lambry JC, Tsai AL, Vos MH, Martin JL. Nitric oxide (NO) traffic in endothelial NO synthase. Evidence for a new NO binding site dependent on tetrahydrobiopterin? J Biol Chem 277:7581-7586, 2002.
48. Werner ER, Pitters E, Schmidt K, Wachter H, Werner-Felmayer G, Mayer B. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J 320:193-196, 1996.
49. Bömmel HM, Reif A, Fröhlich LG, Frey A, Hofmann H, Marecak DM, Groehn V, Kotsonis P, La M, Köster S, Meinecke M, Bernhardt M, Weeger M, Ghisla S, Prestwich GD, Pfleiderer W, Schmidt HHHW. Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase. J Biol Chem 273:33142-33149, 1998.
50. Werner ER, Habisch H-J, Gorren ACF, Schmidt K, Canevari L, Werner-Felmayer G, Mayer B. Contrasting effects of N5-substituted tetrahydrobiopterin derivatives on phenylalanine hydroxylase, dihydropteridine reductase and nitric oxide synthase. Biochem J 348:579-583, 2000.
51. Kotsonis P, Fröhlich LG, Raman CS, Li H, Berg M, Gerwig R, Groehn V, Kang Y, Al-Masoudi N, Taghavi-Moghadam S, Mohr D, Münch U, Schnabel J, Martásek P, Masters BSS, Strobel H, Poulos T, Matter H, Pfleiderer W, Schmidt HHHW. Structural basis for pterin antagonism in nitric-oxide synthase. J Biol Chem 276:49133-49141, 2001.
52. Hurshman AR, Marletta MA. Reactions catalyzed by the heme domain of inducible nitric oxide synthase: evidence for the involvement of tetrahydrobiopterin in electron transfer. Biochemistry 41:3439-3456, 2002.
53. Vásquez-Vivar J, Martásek P, Whitsett J, Joseph J, Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase:an EPR spin trapping study. Biochem J 362:733-739, 2002.
54. Gorren ACF, Kungl AJ, Schmidt K, Werner ER, Mayer B. Electrochemistry of pterin cofactors and inhibitors of nitric oxide synthase. Nitric Oxide 5:176-186, 2001.
55. Riethmüller C, Gorren ACF, Pitters E, Hemmens B, Habisch H-J, Heales SJR, Schmidt K, Werner ER, Mayer B. Activation of neuronal nitric-oxide synthase by the 5-methyl analog of tetrahydrobiopterin. J Biol Chem 274:16047-16051, 1999.
56. Bec N, Gorren ACF, Voelker C, Mayer B, Lange R. Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. J Biol Chem 273:13502-13508, 1998.
57. Abu-Soud HM, Gachhui R, Raushel FM, Stuehr DJ. The ferrousdioxy complex of neuronal nitric oxide synthase. J Biol Chem 272: 17349-17353, 1997.
58. Sato H, Sagami I, Daff S, Shimizu T. Autooxidation rates of neuronal nitric oxide synthase: Effects of the substrates, inhibitors, and modulators. Biochem Biophys Res Commun 253:845-849, 1998.
59. Ledbetter AP, McMillan K, Roman LJ, Masters BSS, Dawson JH, Sono M. Low-temperature stabilization and spectroscopic characterization of the dioxygen complex of the ferrous neuronal nitric oxide synthase oxygenase domain. Biochemistry 38:8014-8021, 1999.
60. Boggs S, Huang L, Stuehr DJ. Formation and reactions of the hemedioxygen intermediate in the first and second steps of nitric oxide synthesis as studied by stopped-flow spectroscopy under single-turnover conditions. Biochemistry 39:2332-2339, 2000.
61. Abu-Soud HM, Presta A, Mayer B, Stuehr DJ. Analysis of neuronal NO synthase under single-turnover conditions:conversion of Nw-hydroxyarginine to nitric oxide and citrulline. Biochemistry 36: 10811-10816, 1997.
62. Hurshman AR, Krebs C, Edmondson DE, Huynh BH, Marletta MA. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. Biochemistry 38:15689-15696, 1999.
63. Witteveen CFB, Giovanelli J, Kaufman S. Reactivity of tetrahydrobiopterin bound to nitric-oxide synthase. J Biol Chem 274:29755-29762, 1999.
64. Bec N, Gorren ACF, Mayer B, Schmidt PP, Andersson KK, Lange R. The role of tetrahydrobiopterin in the activation of oxygen by nitric-oxide synthase. J Inorg Biochem 81:207-211, 2000.
65. Schmidt PP, Lange R, Gorren ACF, Werner ER, Mayer B, Andersson KK. Formation of a protonated trihydrobiopterin radical cation in the first reaction cycle of neuronal and endothelial nitric oxide synthase detected by electron paramagnetic resonance spectroscopy. J Biol Inorg. Chem 6:151-158, 2001.
66. Wei CC, Wang ZQ, Arvai AS, Hemann C, Hille R, Getzoff ED, Stuehr DJ. Structure of tetrahydrobiopterin tunes its electron transfer to the heme-dioxy intermediate in nitric oxide synthase. Biochemistry 42:1969-1977, 2003.
67. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 266:6259-6263, 1991.
68. Gorren ACF, Bec N, Schrammel A, Werner ER, Lange R, Mayer B. Low-temperature optical absorption spectra suggest a redox role for tetrahydrobiopterin in both steps of nitric oxide synthase catalysis. Biochemistry 39:11763-11770, 2000.
69. Huang H, Hah JM, Silverman RB. Mechanism of nitric oxide synthase. Evidence that direct hydrogen atom abstraction from the O-H bond of NG-hydroxyarginine is not relevant to the mechanism. J Am Chem Soc 123:2674-2676, 2001.
70. Heinzel B, John M, Klatt P, Böhme E, Mayer B. Ca2+/calmodulin dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281:627-630, 1992.
71. Gorren ACF, Schrammel A, Riethmüller C, Schmidt K, Koesling D, Werner ER, Mayer B. Nitric oxide-induced autoinhibition of neuronal nitric oxide synthase in the presence of the autoxidation-resistant pteridine 5-methyl-tetrahydrobiopterin. Biochem J 347:475-484, 2000.
72. Mayer B, Werner ER. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiedebergs Arch Pharmacol 351:453-463, 1995.
73. Mayer B, Pfeiffer S, Schrammel A, Koesling D, Schmidt K, Brunner F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 273:3264-3270, 1998.
74. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91: 139-144, 1995.
75. Bagi Z, Koller A. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res 40:47-57, 2003.
76. Yamashiro S, Kuniyoshi Y, Arakaki K, Miyagi K, Koja K. The effect of insufficiency of tetrahydrobiopterin on endothelial function and vasoactivity. Jpn J Thorac Cardiovasc Surg 50:472-477, 2002.
77. Higashi Y, Sasaki S, Nakagawa K, Fukuda Y, Matsuura H, Oshima T, Chayama K. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens 15:326-332, 2002.
78. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281:H981-H986, 2001.
79. Tiefenbacher CP. Tetrahydrobiopterin:a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am J Physiol Heart Circ Physiol 280:H2484-H2488, 2001.
80. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86:E36-E41, 2000.
81. Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110:331-340, 2002.
82. Cai S, Alp NJ, McDonald D, Smith I, Kay J, Canevari L, Heales S, Channon KM. GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells:effects on nitric oxide synthase activity, protein levels and dimerisation. Cardiovasc Res 55:838-849, 2002.
83. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87: 349-354, 2000.
84. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 28:1421-1429, 2000.
85. Heller R, Munscher-Paulig F, Grabner R, Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274:8254-8260, 1999.
86. Huang A, Vita JA, Venema RC, Keaney JF Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275:17399-17406, 2000.
87. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276:40-47, 2001.
88. Baker TA, Milstien S, Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37:333-338, 2001.
89. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103:1618-1623, 2001.
90. d'Uscio LV, Milstien S, Richardson D, Smith L, Katusic ZS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 92:88-95, 2003.
91. Yamashiro S, Noguchi K, Matsuzaki T, Miyagi K, Nakasone J, Sakanashi M, Koja K, Sakanashi M. Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts. J Thorac Cardiovasc Surg 124:775-784, 2002.
92. Patel KB, Stratford MR, Wardman P, Everett SA. Oxidation of tetrahydrobiopterin by biological radicals and scavenging of the trihydrobiopterin radical by ascorbate. Free Radic Biol Med 32:203-211, 2002.
93. Toth M, Kukor Z, Valent S. Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity. Mol Hum Reprod. 8:271-280, 2002.
94. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347:1-16, 2000.
95. Stone KJ. The role of tetrahydrofolate dehydrogenase in the hepatic supply of tetrahydrobiopterin in rats. Biochem J 157:105-109, 1976.
96. Reinhard JF Jr, Chao JY, Smith GK, Duch DS, Nichol CA. A sensitive high-performance liquid chromatographic-fluorometric assay for dihydrofolate reductase in adult rat brain, using 7,8- dihydrobiopterin as substrate. Anal Biochem 140:548-552, 1984.
97. Whiteley JM, Varughese KI, Nguyen NH, Matthews DA, Grimshaw CE. Dihydropteridine reductase. Pteridines 4:159-173, 1993.
98. Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, Masada M, Kikkawa R, Kodama K, Kashiwagi A. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 38:1821-1828, 2001.
99. Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, Kikkawa R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin- resistant rat aorta. Diabetes 48:2437-2445, 1999.
100. Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin- resistant rats. Circ Res 87:566-573, 2000.
101. Viveros OH, Lee CL, Abou-Donia MM, Nixon JC, Nichol CA. Biopterin cofactor biosynthesis: independent regulation of GTP cyclohydrolase in adrenal medulla and cortex. Science 213:349-350, 1981.
102. Verma S, Arikawa E, Yao L, Laher I, McNeill JH. Insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis. Metabolism 47:1037-1039, 1998.
103. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90:107-111, 2002.
104. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656-1662, 2002.
105. Lam KK, Ho ST, Yen MH. Tetrahydrobiopterin improves vascular endothelial function in ovariectomized rats. J Biomed Sci 9: 119-125, 2002.
106. Johns DG, Dorrance AM, Tramontini NL, Webb RC. Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med 226:27-31, 2001.
107. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209, 2003.
108. Vasquez-Vivar J, Duquaine D, Whitsett J, Kalyanaraman B, Rajagopalan S. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler Thromb Vasc Biol 22:1655-1661, 2002.
109. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 101:1530-1537, 1998.
110. Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 79: 336-342, 1996.
111. Tarpey MM. Sepiapterin treatment in atherosclerosis. Arterioscler Thromb Vasc Biol 22:1519-1521, 2002.
112. Canevari L, Land JM, Clark JB, Heales SJ. Stimulation of the brain NO/cyclic GMP pathway by peripheral administration of tetrahydrobiopterin in the hph-1 mouse. J Neurochem 73:2563-2568, 1999.
113. Cosentino F, Barker JE, Brand, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, Luscher TF. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiop-terin-deficient mice. Arterioscler Thromb Vasc Biol 21:496-502, 2001.
114. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109:817-826, 2002.
115. MacCarthy PA, Grieve DJ, Li JM, Dunster C, Kelly FJ, Shah AM. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 104:2967-2974, 2001.
116. Spiekermann S, Landmesser U, Dikalov S, Bredt M, Gamez G, Tatge H, Reepschlager N, Hornig B, Drexler H, Harrison DG. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease:relation to endothelium-dependent vasodilation. Circulation 107:1383-1389, 2003.
117. Rembold H, Metzger H, Sudershan P, Guttensohn W. Catabolism of pteridine cofactors. I. Properties and metabolism in rat liver homogenates of tetrahydrobiopterin and tetrahydroneopterin. Biochim Biophys Acta 184:386-396, 1969.
118. Rembold H, Simmersbach F. Catabolism of pteridine cofactors. II. A specific pterin deaminase in rat liver. Biochim Biophys Acta 184: 589-596, 1969.
119. Rembold H, Chandrashekar V, Sudershan P. Catabolism of pteridine cofactors. IV. In vivo catabolism of reduced pterins in rats. Biochim Biophys Acta 237:365-368, 1971.
120. Haberle DA, Schiffl H, Mayer G, Hennings G, Rembold H. Renal balance of pterin cofactors in the rat. A clearance and micropuncture study. Pflugers Arch 375:9-16, 1978.
121. Wachter H, Hausen A, Grassmayr K. Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases. Hoppe Seylers Z Physiol Chem 360:1957-1960, 1969.
122. Crane BR, Arvai AS, Ghosh S, Getzoff ED, Stuehr DJ, Tainer JA. Structures of the N(omega)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. Biochemistry 39:4608-4621, 2000.
123. Bolin JT, Filman DJ, Matthews DA, Hamlin RC, Kraut J. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem 257:13650-13662, 1982.
124. Reibnegger G, Pauschenwein J, Werner ER. Electronic structure of tetrahydropteridine derivatives. Pteridines 10:91-94, 1999.
125. Schmidt K, Werner-Felmayer G, Mayer B, Werner ER. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur J Biochem 259:25-31, 1999.
126. Gibraeil HD, Dittrich P, Saleh S, Mayer B. Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino- tetrahydrobiopterin. Br J Pharmacol 131:1757-1765, 2000.
127. Bahrami S, Fitzal F, Peichl G, Gasser H, Fuerst W, Banerjee A, Strohmaier W, Redl H, Werner-Felmayer G, Werner ER. Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue. Shock 13:386-391, 2000.
128. Brandacher G, Zou Y, Obrist P, Steurer W, Werner-Felmayer G, Margreiter R, Werner ER. The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival. J Heart Lung Transpl 20:747-749, 2001.
129. Bommel HM, Reif A, Frohlich LG, Frey A, Hofmann H, Marecak DM, Groehn V, Kotsonis P, La M, Koster S, Meinecke M, Bernhardt M, Weeger M, Ghisla S, Prestwich GD, Pfleiderer W, Schmidt HH. Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase. J Biol Chem 273:33142-33149, 1998.
130. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99:41-46, 1997.
131. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87: 264-269, 2002.
132. Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102:2172-2179, 2000.
133. Verma S, Lovren F, Dumont AS, Mather KJ, Maitland A, Kieser TM, Triggle CR, Anderson TJ. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg 120: 668-671, 2000.
134. Maier W, Cosentino F, Lutolf RB, Fleisch M, Seiler C, Hess OM, Meier B, Luscher TF. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol 35:173-178, 2000.
135. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina. Circ J 66:58-62, 2002.
136. Setoguchi S, Hirooka Y, Eshima K, Shimokawa H, Takeshita A. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. J Cardiovasc Pharmacol 39:363-368, 2002.
137. Ueda S, Matsuoka H, Miyazaki H, Usui M, Okuda S, Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. J Am Coll Cardiol 35:71-75, 2000.
138. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:1282-1288, 2001.
139. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284:H528-H534, 2003.
140. Heitzer T, Krohn K, Albers S, Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 43:1435-1438, 2000.
141. Pannirselvam M, Verma S, Anderson TJ, Triggle CR. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db-/-) mice:role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136:255-263, 2002.
142. Prabhakar SS. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol Renal Physiol 281:F179-F188, 2001.
143. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282:H2167-H2172, 2002.
144. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 29:8-15, 1997.
145. Koshimura K, Tanaka J, Murakami Y, Kato Y. Involvement of nitric oxide in glucose toxicity on differentiated PC12 cells: prevention of glucose toxicity by tetrahydrobiopterin, a cofactor for nitric oxide synthase. Neurosci Res 43:31-88, 2002.
146. Tiefenbacher CP, Chilian WM, Mitchell M, DeFily DV. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation 94:1423-1429, 1996.
147. Nakamura K, Wright DA, Wiatr T, Kowlessur D, Milstien S, Lei XG, Kang UJ. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. J Neurochem 74: 2305-2314, 2000.
148. Gramsbergen JB, Sandberg M, Moller DA, Kornblit B, Zimmer J, Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin. Brain Res 935:47-58, 2002.
149. Delgado-Esteban M, Almeida A, Medina JM. Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J Neurochem 82:1148-1159, 2002.
150. Verma S, Maitland A, Weisel RD, Fedak PW, Pomroy NC, Li SH, Mickle DA, Li RK, Rao V. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg 123:1074-1083, 2002.
151. Huisman A, Vos I, van Faassen EE, Joles JA, Grone HJ, Martasek P, van Zonneveld AJ, Vanin AF, Rabelink TJ. Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J 16:1135-1137, 2002.
152. Ferre J, Jacobson KB, Pfleiderer W. Proposal towards a normalization of pteridine nomenclature. Pteridines 2:129-132, 1990.